Zelluna appoints Dr. Namir HassanZelluna Immunotherapy, a biotechnology company specializing in T-cell receptor (TCR) immunotherapies, has announced the appointment of Dr. Namir Hassan as chief scientific officer (CSO). more ➔
Novartis names Klaus Moosmayer as Chief Et...Novartis announced today the appointment of Dr Klaus Moosmayer as Chief Ethics, Risk and Compliance Officer. He will report to Vas Narasimhan, M.D., CEO of Novartis and become a member of the Executive … more ➔
Sphere Fluidics appoints Dr Tris VaughanSphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, announced today that Tris Vaughan, PhD FRSB has joined its scientific advisory board … more ➔
Cellectis Appoints Stefan SchererCellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced today the appointment of Dr. Stefan Scherer, … more ➔
Cell Medica Appoints New CEOCell Medica, a company active in the development, manufacture and marketing of personalised cellular immunotherapeutics for the treatment of cancer, has appointed Chris Nowers as Chief Executive Officer … more ➔
Marinomed Biotech Appoints New CFOPascal Schmidt appointed CFO as Vienna based biotech firm Marinomedas of August 1 2018. more ➔
Morphosys launches US subsidiary, appoints...Morphosys has named Jennifer Herron President of MorphoSys US Inc. to build up sales presence overseas. more ➔
Lundbeck names new president and CEOThe Board of Directors of the company has appointed Dr. Deborah Dunsire as new president and CEO of Lundbeck. Deborah Dunsire will take up her new position on 1 September 2018. more ➔
Corbion CEO de Ruiter named new EuropaBio...EuropaBios Executive Board and General Assembly of Members this week confirmed the appointment of Tjerk de Ruiter as Chairman of the association. more ➔
Symcel appoints two new board membersSymcel has announced the appointment of two new board members; Erik Walldén and Stefan Löfås. Both will play a key role in the companys corporate strategy to grow business in the research market … more ➔
